HORIZON PHARMACEUTICAL LLC
DelistedCIK 1070698fmd_10NN8RWX4C64GXXC0ANYKJ3H8TManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 08, 2005 to Jun 30, 2016, 33 periods
| Line item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 0 | 17 | 69 | 94 |
| Cost of revenue | – | – | – | – | – | – | – | 2 | 9 | 13 |
| Gross profit | – | – | – | – | – | – | – | 15 | 60 | 82 |
| Research and development | – | – | – | – | 9 | 15 | 21 | 29 | 43 | 59 |
| Total operating expenses | – | – | – | – | 13 | 21 | 36 | 67 | 100 | 130 |
| Operating income | – | – | – | – | (13) | (21) | (36) | (52) | (40) | (48) |
| Interest expense | – | – | – | – | 0 | 0 | 0 | 7 | 14 | 16 |
| Interest and investment income | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | – | – | – | – | – | – | – | (69) | (52) | (65) |
| Income tax expense | – | – | – | – | – | – | – | 0 | (0) | (0) |
| Net income from continuing operations | – | – | – | – | – | – | – | (69) | (52) | (64) |
| Net income | (1) | (4) | (8) | (9) | (19) | (37) | (39) | (69) | (53) | (65) |